Labena Ventures’ Post

🚀 Meet Our Advisors! We are excited to highlight that Nola E. Masterson, Venture Partner at Portfolia, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Nola E. Masterson "Nola has over 40 years of experience building and supporting biotech companies as an investor, entrepreneur, and consultant. She currently funds biotech ventures through Portfolia Femtech Funds. Her extensive background and commitment to advancing biotech innovation make her a key player in the industry." 🌷Apply now to learn invaluable insights from Nola E. Masterson and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel

🚀 Meet Our Advisors! We are excited to highlight that Nola E. Masterson, Venture Partner at Portfolia, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Nola E. Masterson "Nola has over 40 years of experience building and supporting biotech companies as an investor, entrepreneur, and consultant. She currently funds biotech ventures through Portfolia Femtech Funds. Her extensive background and commitment to advancing biotech innovation make her a key player in the industry." 🌷Apply now to learn invaluable insights from Nola E. Masterson and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel

Our latest #SVBHealthcare report found that 68 biotech startups have raised $100M+ venture funding rounds so far this year. Check out this WSJ article for a look at what’s behind these mega-rounds and what the trend means for the VC-backed biotech ecosystem. https://lnkd.in/gCZM_Xv9

The #biotechnology industry has become a beacon of innovation and progress, driving advancements in healthcare, life sciences, and related fields. Central to this ecosystem's growth are the seed & angel investors who provide crucial funding and support to early-stage #biotech startups. The biotech seed and angel investment landscape in 2024 is dynamic and full of potential. For entrepreneurs in this space, finding the right investors is more than securing funds. It's about building relationships with partners who can provide guidance, expertise & networks to help navigate the complex biotech landscape. The future looks bright for biotech startups that can leverage these opportunities effectively.

Biotech and health companies have garnered a staggering $5.6 billion across 110 Series A rounds in 2024, according to Crunchbase data. This accounts for a remarkable 53% of all funding at the Series A stage, which is a critical barometer for the startup ecosystem. The numbers are a testament to the growing investor interest in healthcare and biotech. #Biotech #Healthcare #SeriesA #Funding #Startups #Investments https://lnkd.in/eEDkp7i5

Interested? Check the link below to learn more

This Weeks 10 Biggest Funding Rounds (via @Crunchbase) 👍 This week witnessed another surge of substantial funding rounds, notably led by the biotech sector, with three startups securing positions in the top five. March appears to be continuing the trend set by February, with #investors demonstrating a growing willingness to invest significant sums in promising ventures. Read more: https://loom.ly/_eQ7M28 #vc #venturecapital #venturefunding #funding

"It's not just about getting funded; it's about having a clear vision of how our work can change lives." Read on as KKH Advisors' Kimberly Ha discusses navigating the biotech startup waters, including: ✅ What the most successful biotech companies have in common ✅ What investors want to see before funding a company ✅ The tools early-stage companies need to create a compelling narrative Full article on pg. 22 here: https://lnkd.in/geAMt25x #Biotech #Biotechnology #BiotechStartup #Startups

🔬✨ Thanks to everyone who joined our recent poll about the top challenges for biotech start-ups! Your insights are helpful for understanding our industry better. Looks like 40% of you think funding is the primary hurdle. No surprises there! Getting the cash flow needed isn't just about starting up; it's about keeping the innovation going, driving research forward, and getting life-changing products out there. At Ellab, we understand the critical role funding plays in the success of biotech ventures. That's why we're dedicated to supporting startups. From providing strategic advice on setup and ongoing compliance to save you valuable time and resources, to offering equipment rental options that spare you from large capital expenses while ensuring access to top-quality technology – we've got you covered. We're here to help you navigate the bumpy road from idea to market. Let us help you unlock the full potential of biotechnology. Get in touch with your local team to discuss any validation, monitoring, calibration or consultancy needs https://lnkd.in/eNp9CNph #Biotech #Startups #Funding #Innovation #Collaboration

Biotech startups often require substantial initial capital to support extensive research and development, clinical trials, and regulatory approvals before generating any revenue.   Our Investment Director, Michael Salako PhD MBA, recently spoke to Labiotech.eu, offering his advice to biotech startups trying to navigate the complex funding landscape.   When tackling the VC landscape, Michael advises biotech startups to be cautious and organised. “They should have a light touch non-confidential deck to send out and set the scene and a longer, more technical non-confidential deck that they can quickly talk to on a call if afforded the chance."   For more practical advice on choosing the right approach, read the full article here: https://rb.gy/smbt2h   #Biotech #StartUps #Funding #Fund #VentureBuilder